SCM
MRNS
Suvretta Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,073,913
| Closed | -$8.93M | – | 115 |
|
|
2024
Q3 | $8.93M | Buy |
5,073,913
+1,253,901
| +33% | +$2.21M | 0.29% | 53 |
|
|
2024
Q2 | $4.47M | Sell |
3,820,012
-1,288,508
| -25% | -$1.51M | 0.16% | 53 |
|
|
2024
Q1 | $46.2M | Sell |
5,108,520
-237,599
| -4% | -$2.15M | 1.72% | 18 |
|
|
2023
Q4 | $58.1M | Buy |
5,346,119
+141,177
| +3% | +$1.53M | 2.63% | 11 |
|
|
2023
Q3 | $41.9M | Buy |
5,204,942
+1,147,331
| +28% | +$9.24M | 2.26% | 13 |
|
|
2023
Q2 | $44.1M | Sell |
4,057,611
-773,650
| -16% | -$8.4M | 2.36% | 12 |
|
|
2023
Q1 | $33.3M | Buy |
4,831,261
+8,266
| +0.2% | +$57K | 1.41% | 27 |
|
|
2022
Q4 | $19.2M | Buy |
4,822,995
+1,285,295
| +36% | +$5.12M | 0.81% | 42 |
|
|
2022
Q3 | $23.5M | Buy |
3,537,700
+26,869
| +0.8% | +$179K | 0.98% | 40 |
|
|
2022
Q2 | $17M | Buy |
3,510,831
+744,831
| +27% | +$3.6M | 0.65% | 48 |
|
|
2022
Q1 | $25.9M | Buy |
2,766,000
+127,225
| +5% | +$1.19M | 0.79% | 40 |
|
|
2021
Q4 | $31.3M | Buy |
2,638,775
+441,349
| +20% | +$5.24M | 0.61% | 41 |
|
|
2021
Q3 | $25M | Buy |
2,197,426
+370,981
| +20% | +$4.22M | 0.42% | 45 |
|
|
2021
Q2 | $32.8M | Hold |
1,826,445
| – | – | 0.49% | 46 |
|
|
2021
Q1 | $28.3M | Buy |
1,826,445
+396,273
| +28% | +$6.13M | 0.42% | 50 |
|
|
2020
Q4 | $17.4M | Buy |
1,430,172
+650,447
| +83% | +$7.94M | 0.25% | 55 |
|
|
2020
Q3 | $10M | Sell |
779,725
-1,220,275
| -61% | -$15.7M | 0.18% | 53 |
|
|
2020
Q2 | $5.08M | Buy |
+2,000,000
| New | +$5.08M | 0.11% | 56 |
|